Participant & Public Involvement

Participant and public involvement (PPI) has played a central role in the development of the SELPHI study. Our PPI strategy aims to involve participants and members of the public throughout the lifecycle of the SELPHI clinical trial (click here to read the full strategy).

Participant and public involvement in SELPHI has already had a number of achievements to date, such as establishing a simplified language style for participant information, inclusion of trans* individuals as part of the CAG and the inclusion of trans women in the SELPHI study.

The membership of each of the SELPHI groups are listed below:

Members of the public are represented on the Trial Management Group (TMG) and the Core Group.

A community advisory group comprising 28 members of the public advise the trial team on the running of the study.

Name

Organisation

Aedan Wolton

cliniQ

Andrew Gill

Personal capacity

Ben Cromarty

North Yorkshire AIDS Action

Harry Dodd

Personal capacity

Kat Smithson

Policy and Campaigns Manager, NAT

Marc Thompson

National Coordinator, Project 100. Positively UK

Michelle Ross

Co-Founder cliniQ

Roger Pebody (co-chair)

NAM

Roy Trevelion (co-chair)

HIV i-Base

Simon Collins

HIV i-Base


Plus 18 other members, some of whom have elected to remain anonymous

A stakeholder eGroup including representatives from community based organisations and HIV charities across England and Wales support and advise the study team.

Name

Organisation

Aedan Wolton

cliniQ

Cary James

THT

Jamie Pallas

Gender Intelligence

Kate Nambiar

Clinic T

Louie Stafford

LGBT Foundation

Mark Santos

Positive East

Michelle Ross

cliniQ

Monty Moncrieff

London Friend

Paul Steinberg

Do-it London

Rob Cookson

LGBT Foundation

Roger Pebody

NAM

Roy Trevelion

i-base

Simon Collins

i-base

Stephan Gampenrieder

THT Direct

Zahra Jamal

NAZ Project

SELPHI participants will be invited to contribute to ad hoc PPI meetings via the participant mailing list.

Further Information

Latest PPI News
Jul 6, 2017, 9:26 AM
May 31, 2017, 10:56 AM
May 12, 2017, 12:58 PM